Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
暂无分享,去创建一个
Keiron O'Shea | Chuan Lu | L. Mur | S. Cameron | K. Lewis | Keir E Lewis | K. O’Shea | Chuan Lu | Simon J S Cameron | Luis A J Mur | Simon J. S. Cameron
[1] Tobias Faust. Pathology And Genetics Of Tumours Of The Lung Pleura Thymus And Heart , 2016 .
[2] F. Aguayo,et al. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers , 2012, Diagnostic Pathology.
[3] Amoroso,et al. Nephrology Dialysis Transplantation , 1999 .
[4] Brian L Hood,et al. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. , 2010, Journal of proteome research.
[5] A. Shelton,et al. Changes in neuronal activation patterns in response to androgen deprivation therapy: a pilot study , 2010, BMC Cancer.
[6] J. Jankowski,et al. Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. , 2003, The Journal of clinical investigation.
[7] J. Jankowski,et al. The uraemic toxin phenylacetic acid impairs macrophage function. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[8] M. Beckmann,et al. The metabolomic detection of lung cancer biomarkers in sputum. , 2016, Lung cancer.
[9] Enyou Li,et al. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation , 2014, Scientific Reports.
[10] D. Timmerman,et al. Using artificial neural networks to predict malignancy of ovarian tumors , 2001, 2001 Conference Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[11] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[12] Rich Caruana,et al. Overfitting in Neural Nets: Backpropagation, Conjugate Gradient, and Early Stopping , 2000, NIPS.
[13] E. Thunnissen,et al. Molecular sputum analysis for the diagnosis of lung cancer , 2013, British Journal of Cancer.
[14] H. Matsumoto,et al. Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy , 2012, Biomolecules.
[15] M. Fiegl,et al. Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.
[16] W. Hörl,et al. The uraemic toxin phenylacetic acid contributes to inflammation by priming polymorphonuclear leucocytes. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[17] Geoffrey E. Hinton,et al. Learning internal representations by error propagation , 1986 .
[18] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[19] Y. Wu,et al. Artificial neural networks in mammography: application to decision making in the diagnosis of breast cancer. , 1993, Radiology.
[20] D. Kavanagh,et al. Is overexpression of HER-2 a predictor of prognosis in colorectal cancer? , 2009, BMC Cancer.
[21] Jstor. Journal of the Royal Statistical Society. Series D, (The statistician) , 1993 .
[22] Elisabeth Brambilla,et al. Pathology and genetics of tumours of the lung , pleura, thymus and heart , 2004 .
[23] Yoshua Bengio,et al. Random Search for Hyper-Parameter Optimization , 2012, J. Mach. Learn. Res..
[24] D. Samid,et al. Phase I study of phenylacetate administered twice daily to patients with cancer , 1995, Cancer.
[25] Hongwei Li,et al. Metabolomic profiling of human serum in lung cancer patients using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry and gas chromatography/mass spectrometry , 2015, Journal of Cancer Research and Clinical Oncology.
[26] A. Andermann,et al. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. , 2008, Bulletin of the World Health Organization.
[27] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[28] A. Lloyd,et al. Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum , 2010, BMC Cancer.
[29] M. Ringnér,et al. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.
[30] B. Bergman,et al. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues. , 2000, Lung cancer.
[31] J. Lowe,et al. Fucose: biosynthesis and biological function in mammals. , 2003, Glycobiology.
[32] N. Shah,et al. Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis , 2012 .
[33] Paulo J. G. Lisboa,et al. The Use of Artificial Neural Networks in Decision Support in Cancer: a Systematic Review , 2005 .
[34] Ø. Langsrud,et al. 50–50 multivariate analysis of variance for collinear responses , 2002 .
[35] R. Cataneo,et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.
[36] R. Dybowski,et al. Artificial neural networks in pathology and medical laboratories , 1995, The Lancet.